| AZN |
AstraZeneca
|
FTSE 100
| 2.32 |
£158.66B
| 10,352.00 | 1.17% |
| GSK |
GSK
|
FTSE 100
| 4.54 |
£54.87B
| 1,347.50 | 0.26% |
| HLN |
Haleon
|
FTSE 100
| 1.86 |
£31.83B
| 355.00 | 0.20% |
| SN. |
Smith & Nephew
|
FTSE 100
| 2.48 |
£9.89B
| 1,137.50 | 0.80% |
| CTEC |
ConvaTec Group
|
FTSE 100
| 1.98 |
£4.93B
| 241.00 | 0.25% |
| HIK |
Hikma Pharmaceuticals
|
FTSE 100
| 2.96 |
£4.43B
| 1,985.00 | -0.65% |
| HCM |
Hutchmed China
|
AIM
| |
£2.17B
| 261.50 | 4.80% |
| GNS |
Genus
|
FTSE 250
| 1.33 |
£1.59B
| 2,420.00 | 0.41% |
| INDV |
Indivior
|
FTSE 250
| |
£1.46B
| 1,183.00 | -3.10% |
| SPI |
Spire Healthcare Group
|
FTSE 250
| 1.02 |
£906.21M
| 225.00 | 0.00% |
| UPR |
Uniphar
|
AIM
| 0.01 |
£839.93M
| 318.40 | 0.90% |
| AMS |
Advanced Medical Solutions Group
|
AIM
| 1.24 |
£444.89M
| 205.00 | 3.10% |
| OXB |
Oxford BioMedica
|
FTSE Small Cap
| |
£398.01M
| 374.00 | -0.27% |
| AGY |
Allergy Therapeutics
|
AIM
| |
£381.32M
| 8.00 | -2.50% |
| PRTC |
Puretech Health
|
FTSE Small Cap
| |
£332.64M
| 136.00 | -1.59% |
| NIOX |
Niox Group
|
AIM
| 1.81 |
£288.12M
| 69.00 | |
| FARN |
Faron Pharmaceuticals OY
|
AIM
| |
£229.51M
| 198.00 | 1.10% |
| ANCR |
Animalcare Group
|
AIM
| 1.72 |
£200.07M
| 292.00 | -2.60% |
| TSTL |
Tristel
|
AIM
| 3.38 |
£190.85M
| 397.00 | 1.60% |
| BMK |
Benchmark Holdings
|
AIM
| |
£184.12M
| 24.80 | 1.50% |
| MXCT |
Maxcyte Inc
|
AIM
| |
£161.75M
| 147.69 | -1.20% |
| 4BB |
4basebio
|
AIM
| |
£147.04M
| 965.00 | -0.40% |
| BVXP |
Bioventix
|
AIM
| 5.69 |
£142.38M
| 2,725.00 | -2.20% |
| AVCT |
Avacta Group
|
AIM
| |
£131.18M
| 34.00 | -7.00% |
| EKF |
EKF Diagnostics Holdings
|
AIM
| |
£119.91M
| 26.70 | 1.00% |
| DXRX |
Diaceutics
|
AIM
| |
£107.37M
| 133.00 | -0.50% |
| SCLP |
Scancell Holdings
|
AIM
| |
£106.32M
| 10.25 | -1.10% |
| SDI |
SDI Group
|
AIM
| |
£98.28M
| 93.00 | -1.50% |
| ANIC |
Agronomics
|
AIM
| |
£91.05M
| 9.10 | -0.60% |
| ANP |
Anpario
|
AIM
| 2.94 |
£78.2M
| 385.00 | -0.90% |
| HVO |
Hvivo
|
AIM
| 2.00 |
£68.04M
| 10.00 | -5.10% |
| OBI |
Ondine Biomedical Inc
|
AIM
| |
£58.75M
| 13.25 | 2.60% |
| CREO |
Creo Medical Group
|
AIM
| |
£52.32M
| 13.50 | -0.80% |
| EAH |
Eco Animal Health Group
|
AIM
| |
£52.17M
| 77.66 | -4.30% |
| SPEC |
Inspecs Group
|
AIM
| |
£44.63M
| 42.20 | -0.30% |
| SBTX |
SkinBioTherapeutics
|
AIM
| |
£42.7M
| 16.63 | -14.90% |
| KMK |
Kromek Group
|
AIM
| |
£38.64M
| 5.70 | 8.70% |
| FUM |
Futura Medical
|
AIM
| |
£35.78M
| 12.65 | 14.60% |
| STX |
Shield Therapeutics
|
AIM
| |
£35.42M
| 3.55 | -7.90% |
| NCYT |
Novacyt SA
|
AIM
| |
£28.75M
| 40.45 | 4.20% |
| SAR |
Sareum Holdings
|
AIM
| |
£24.37M
| 17.22 | -5.60% |
| ABDX |
Abingdon Health
|
AIM
| |
£23.5M
| 6.50 | 2.60% |
| TRX |
Tissue Regenix Group
|
AIM
| |
£23.15M
| 37.00 | -1.50% |
| POLB |
Poolbeg Pharma
|
AIM
| |
£21.61M
| 3.10 | -2.10% |
| AGL |
Angle
|
AIM
| |
£20.9M
| 5.75 | -0.70% |
| IHC |
Inspiration Healthcare Group
|
AIM
| |
£18.83M
| 21.50 | 0.60% |
| AREC |
Arecor Therapeutics
|
AIM
| |
£18.69M
| 51.50 | -1.30% |
| EDEN |
Eden Research
|
AIM
| |
£17.6M
| 3.30 | -2.40% |
| POLX |
Polarean Imaging
|
AIM
| |
£13.88M
| 1.12 | -3.20% |
| COG |
Cambridge Cognition Holdings
|
AIM
| |
£13.61M
| 32.50 | -0.40% |
| IMM |
ImmuPharma
|
AIM
| |
£11.62M
| 2.07 | -3.00% |
| OPTI |
OptiBiotix Health
|
AIM
| |
£11.62M
| 11.25 | -3.30% |
| OBD |
Oxford BioDynamics
|
AIM
| |
£11.06M
| 0.50 | -4.00% |
| IXI |
Ixico
|
AIM
| |
£9.92M
| 11.20 | -1.50% |
| FAB |
Fusion Antibodies
|
AIM
| |
£9.26M
| 7.96 | 25.90% |
| CEL |
Celadon Pharmaceuticals
|
AIM
| |
£9.23M
| 13.40 | |
| PRM |
Proteome Sciences
|
AIM
| |
£8.97M
| 3.04 | 8.00% |
| GDR |
Genedrive
|
AIM
| |
£8.75M
| 1.40 | -1.60% |
| RUA |
RUA Life Sciences
|
AIM
| |
£7.29M
| 11.75 | -6.90% |
| SUN |
Surgical Innovations Group
|
AIM
| |
£6.53M
| 0.70 | -2.30% |
| MHC |
MyHealthChecked
|
AIM
| |
£6.5M
| 11.75 | 5.30% |
| GENI |
Genincode
|
AIM
| |
£5.45M
| 1.95 | 1.40% |
| BELL |
Belluscura
|
AIM
| |
£3.01M
| 0.73 | -1.10% |
| VAL |
ValiRx
|
AIM
| |
£2.25M
| 0.60 | -2.20% |
| PYC |
Physiomics
|
AIM
| |
£1.44M
| 0.46 | -3.80% |
| VRCI |
Verici Dx
|
AIM
| |
£1.41M
| 0.60 | -4.80% |
| GUN |
Gunsynd
|
AIM
| |
£1.17M
| 0.11 | 9.50% |
| TRLS |
Trellus Health
|
AIM
| |
–
| 0.60 | 7.30% |
| TLY |
Totally
|
AIM
| |
–
| 0.24 | -1.90% |